|
End-of-day quote
Nasdaq
27/10/2026
|
5-day change | 1st Jan Change | ||
| 8.890 USD | -3.47% |
|
-5.43% | -39.73% |
| 09-01 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Evolution of the Average Target: Daxor Corporation
Evolution of the Target Price: Daxor Corporation
Changes in Analyst Recommendations: Daxor Corporation
bd4ba3b.ZvZUi1jI35GggXwD6oMnvZhjJ4lEr4Q1ROVcGVzEnkw.NpQ42y34hsbVwksuneZ2-MwZd-h0zsxgINYzUg2d1yAUpXnnG4OOp8zIHw~f3dea263ca1b60e7492f049d9506b098


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
9.200USD
Average target price
20.00USD
Spread / Average Target
+117.39%
High Price Target
22.00USD
Spread / Highest target
+139.13%
Low Price Target
18.00USD
Spread / Lowest Target
+95.65%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- DXR Stock
- Consensus Daxor Corporation
Select your edition
All financial news and data tailored to specific country editions
















